Incyte Pulls Parsaclisib Files As FDA Takes Foot Off Accelerator

Was Seeking Accelerated Approval For PI3K inhibitor For Lymphoma

red lights
FDA no longer keen on accelerated approval green lights • Source: Alamy

More from Anticancer

More from Therapeutic Category